表紙：臨床試験患者募集サービスの2030年までの市場予測：治療分野別、フェーズ別、年齢層別、地域別の世界分析

市場調査レポート

商品コード

1383404

臨床試験患者募集サービスの2030年までの市場予測：治療分野別、フェーズ別、年齢層別、地域別の世界分析

Clinical Trial Patient Recruitment Services Market Forecasts to 2030 - Global Analysis By Therapeutic Areas, Phase, Age Group and By Geography

出版日: 2023年11月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 649,807円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,045円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 994,283円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,174,350円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、臨床試験患者募集サービスの世界市場は2023年に11億9,000万米ドルを占め、予測期間中にCAGR 11.5％で成長し、2030年には25億5,000万米ドルに達すると予測されています。

研究者や製薬会社が臨床試験に適格な臨床試験患者を見つけ、募集するのを支援するために特別に設計されたサービスは、臨床試験患者募集サービスとして知られています。臨床試験をより迅速に開始するために、患者募集サービスは適格な参加者の特定と登録のプロセスをスピードアップすることができます。研究者が様々な人口集団における治療法の有効性と安全性をよりよく理解するためには、より多様で代表的な患者集団を確保することが不可欠であり、これは患者募集サービスが確保できる要素です。

ClinicalTrial.govによると、臨床試験は過去5年間で49.2％増加しています。

臨床試験数の増加

臨床試験患者募集サービスの市場を促進している主な要因の1つは、臨床試験件数の増加です。製薬研究、医学研究、新規療法や治療法の探索における継続的な開発が、臨床試験活動増加の主な原動力となっています。製薬・バイオテクノロジー企業、学術機関、研究機関が新薬、医療機器、治療法の市場導入に向けた取り組みを強化する中、専門的な患者募集サービスの需要が高まっています。

予算の制約

予算上の制約は、研究機関や製薬会社にとって典型的な問題です。患者リクルートサービスは治験の円滑な実施に不可欠ですが、そのコストは大きな要因となります。これらのサービスには通常、スタッフの雇用、最先端技術の使用、広告、可能性のある臨床試験参加者を見つけて結びつけるためのアウトリーチプログラムなど、多くの費用がかかります。さらに、患者リクルートサービスのプロバイダーは、競争の激しい市場で競合価格設定を提供することにプレッシャーを感じる可能性があり、利益率や最先端の戦術や技術への投資能力に影響を与える可能性があります。そのため、市場成長の大きな障壁となっています。

先端技術

数多くの人材紹介会社が、人工知能やデータ分析のような先端技術を利用して、参加者の識別精度と効率を向上させています。データ解析は、大規模なデータセットを選別することで、可能性のある臨床試験参加者を迅速かつ正確に特定するために、患者募集サービスで利用される機会が増えています。この分析手法により、患者のさまざまな特徴や病歴を系統的に評価することで、各臨床試験の正確な要件に適合する人々を特定することが可能になります。このような要因が市場の需要を後押ししています。

規制上の課題

臨床試験の規制状況は複雑で、常に変化しています。人材紹介会社は、データ保護やインフォームド・コンセントに関する規制など、変化する規制を遵守し続けることが困難な場合があります。さらに、臨床試験に適用される患者のプライバシー、データ保護、インフォームド・コンセントに関する厳しい規制もあります。患者募集サービスでは、患者データの収集、保存、共有に関して、規制機関の厳しいガイドラインを遵守することが困難な場合があります。こうした要因が市場拡大の妨げとなっています。

COVID-19の影響

COVID-19パンデミックは臨床試験患者募集サービス市場に大きな影響を与えました。進行中の数多くの臨床試験がパンデミックによって中断され、臨床試験の登録と患者募集に大きな悪影響を及ぼしました。フェーズアウト、渡航禁止、医療施設へのアクセス制限により、治験を予定通りに実施することが困難になっています。遠隔モニタリング機能を向上させ、直接訪問の必要性を最小限に抑えながらリアルタイムの患者データを収集するため、患者募集サービスはハイテク企業と協力しました。

予測期間中、呼吸器疾患分野が最大となる見込み

呼吸器疾患分野が最大のシェアを占めると推定されます。臨床試験患者募集サービスの呼吸器疾患部門は、さまざまな呼吸器疾患の治療法や治療法の創出に取り組む臨床研究の特定分野に焦点を当てています。肺機能の強化、症状の軽減、増悪の阻止を目的とした新規薬剤、吸入薬、生物学的製剤、医療機器の安全性と有効性を評価する目的で、臨床試験は極めて重要です。

フェーズIIセグメントは予測期間中最も高いCAGRが見込まれる

フェーズIIセグメントは予測期間中に有利な成長を遂げると予測されています。臨床研究において、フェーズII臨床試験は第I相試験の後、フェーズIII試験の前に行われる重要な段階です。第II相臨床試験の主な目的は、より多くの患者集団で新しい治療法や薬の安全性と有効性を評価することです。フェーズIIの臨床試験患者募集サービスは、治験実施計画書に明記された正確な要件を満たす適格な参加者を特定し、登録する役割を担っています。

最もシェアの高い地域

北米では活発な臨床試験が数多く実施されているため、推定期間中に最大の市場シェアを占め、市場の急速な拡大が予想されます。また、臨床試験に対する多額の研究開発費と政府からの資金援助も業界を牽引しています。北米における業界の成長は、患者のリクルートなど広範なサポートサービスを提供するトップクラスの開発業務受託機関（CRO）の存在や、世界の製薬企業やバイオ医薬品企業の積極的な関与によって促進されています。

CAGRが最も高い地域：

アジア太平洋は、予測期間中に収益性の高い成長を遂げると予想されます。インド、日本、韓国などの新興国への臨床試験のオフショアリングが増加しています。これは、患者プールが多く、臨床試験が安価であるためで、地域拡大がさらに促進されます。有能な医療従事者の確保、強固な病院ネットワーク、研究開発インフラの整備などが、アジア太平洋市場の拡大に寄与しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場参入企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

イントロダクション
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東およびアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東およびアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

Clinical Site Services
Clara Health
Worldwide Clinical Trials
Clariness
Veristat
PPD Inc
BBK Worldwide
Elligo Health Research
Antidote Technologies, Inc.
IQVIA
Matthews Media Group Inc.
Conduent, Inc.
Biorasi, LLC
Trialfacts
Syneos Health

図表

List of Tables

Table 1 Global Clinical Trial Patient Recruitment Services Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 3 Global Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 4 Global Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 5 Global Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 6 Global Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 7 Global Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 8 Global Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 9 Global Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 10 Global Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 11 Global Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 12 Global Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 13 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 14 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 15 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 16 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 17 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 18 Global Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 19 Global Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 20 Global Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 21 North America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 22 North America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 23 North America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 24 North America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 25 North America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 26 North America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 27 North America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 28 North America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 29 North America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 30 North America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 31 North America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 32 North America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 33 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 34 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 35 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 36 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 37 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 38 North America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 39 North America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 40 North America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 41 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 42 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 43 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 44 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 45 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 46 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 47 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 48 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 49 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 50 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 51 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 52 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 53 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 54 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 55 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 56 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 57 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 58 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 59 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 60 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 61 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 62 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 63 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 64 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 65 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 66 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 67 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 68 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 69 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 70 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 71 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 72 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 73 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 74 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 75 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 76 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 77 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 78 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 79 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 80 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 81 South America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 82 South America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 83 South America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 84 South America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 85 South America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 86 South America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 87 South America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 88 South America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 89 South America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 90 South America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 91 South America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 92 South America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 93 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 94 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 95 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 96 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 97 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 98 South America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 99 South America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 100 South America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
Table 101 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
Table 102 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
Table 103 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
Table 104 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
Table 105 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
Table 106 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
Table 107 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 108 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
Table 109 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
Table 110 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
Table 111 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
Table 112 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
Table 113 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
Table 114 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
Table 115 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
Table 116 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
Table 117 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
Table 118 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
Table 119 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
Table 120 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)

Product Code: SMRC24253

According to Stratistics MRC, the Global Clinical Trial Patient Recruitment Services Market is accounted for $1.19 billion in 2023 and is expected to reach $2.55 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Services specifically designed to assist researchers and pharmaceutical companies in finding and recruiting qualified subjects for their clinical trials are known as clinical trial patient recruitment services. In order to help clinical trials get underway more quickly, patient recruitment services can speed up the process of identifying and enrolling eligible participants. For researchers to better understand a treatment's efficacy and safety across a range of demographic groups it is imperative to have a more diverse and representative patient population, which is a factor that patient recruitment services can help ensure.

According to ClinicalTrial.gov, there has been a 49.2% rise in clinical trials over the past 5 years.

Market Dynamics:

Driver:

Rising Number of Clinical Trials

One major factor propelling the market for clinical trial patient recruitment services is the rise in the number of clinical trials. The ongoing developments in pharmaceutical research, medical research, and the search for novel therapies and treatments are the main drivers of this rise in clinical trial activity. Specialized patient recruitment services are in increasing demand as pharmaceutical and biotechnology companies, academic institutions, and research organizations step up their efforts to introduce novel drugs, medical devices, and therapies to the market.

Restraint:

Budgetary restrictions

Budgetary restrictions are a typical problem for research institutions and pharmaceutical companies. Although patient recruitment services are essential to the smooth running of trials, their costs can be a significant factor. These services usually come with a number of costs, such as hiring staff, using cutting-edge technologies, advertising, and outreach programs to find and connect possible trial participants. Furthermore, providers of patient recruitment services may feel pressured to offer competitive pricing in a market that is fiercely competitive, which could affect their profit margins and capacity to make investments in cutting-edge tactics and technologies. Therefore, it is a significant barrier to market growth.

Opportunity:

Advanced technologies

Numerous recruitment agencies use advanced technologies, like artificial intelligence and data analytics, to improve participant identification accuracy and efficiency. Data analytics is being used by patient recruitment services in increasing numbers to quickly and accurately identify possible trial participants by sorting through large datasets. This analytical method makes it possible to identify people who fit the precise requirements of each clinical trial by methodically evaluating a variety of patient characteristics and medical histories. These factors propel market demand.

Threat:

Regulatory challenges

The regulatory landscape for clinical trials is complex and subject to constant change. Recruitment agencies may find it difficult to remain compliant with changing regulations, such as those pertaining to data protection and informed consent. Additionally, there are stringent regulations pertaining to patient privacy, data protection, and informed consent that apply to clinical trials. Patient recruitment services may find it difficult to comply with regulatory bodies' strict guidelines when it comes to gathering, storing, and sharing patient data. These factors hamper market expansion.

COVID-19 Impact

The COVID-19 pandemic has had a significant impact on the clinical trial patient recruitment services market. Numerous ongoing clinical trials were disrupted by the pandemic, which had a significant negative impact on trial enrolment and patient recruitment. Phase-outs, travel bans, and restricted access to medical facilities made it difficult to carry out trials as scheduled. In order to improve remote monitoring capabilities and collect real-time patient data while minimizing the need for in-person visits, patient recruitment services worked with tech companies.

The respiratory diseases segment is expected to be the largest during the forecast period

The respiratory diseases segment is estimated to hold the largest share. The Clinical Trial Patient Recruitment Services' respiratory diseases section focuses on a particular field of clinical research that is committed to the creation of cures and treatments for a range of respiratory ailments. For the purpose of assessing the safety and effectiveness of novel medications, inhalers, biologics, and medical devices intended to enhance lung function, reduce symptoms, or stop exacerbations, clinical trials are crucial.

The phase II segment is expected to have the highest CAGR during the forecast period

The phase II segment is anticipated to have lucrative growth during the forecast period. In the clinical research spectrum, Phase II clinical trials are a crucial stage that comes after Phase I trials and before Phase III trials. The main goals of Phase II trials are to evaluate a new treatment or medication's safety and effectiveness in a larger patient population. The Phase II segment recruitment services are responsible for identifying and enrolling eligible participants who meet the precise requirements specified in the trial protocol.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the large number of active clinical trials in the region, the market is anticipated to increase rapidly. Significant R&D expenditures and government funding for clinical studies also drive the industry. The industry's growth in North America has been facilitated by the existence of top contract research organizations (CROs) that provide extensive support services, such as patient recruiting, and by the active involvement of global pharmaceutical and biopharmaceutical corporations.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. There is an increase in off shoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is because there is a large patient pool and trials are inexpensive, which further promotes regional expansion. The availability of qualified medical professionals, a robust hospital network, and developed clinical research infrastructure are all contributing to the Asia-Pacific market's expansion.

Key players in the market

Some of the key players in the Clinical Trial Patient Recruitment Services Market include: Clinical Site Services, Clara Health, Worldwide Clinical Trials, Clariness, Veristat, PPD Inc, BBK Worldwide, Elligo Health Research, Antidote Technologies, Inc., IQVIA, Matthews Media Group Inc., Conduent, Inc., Biorasi, LLC, Trialfacts and Syneos Health.

Key Developments:

In August 2023, Worldwide Clinical partners with Cybin for psychedelic-based treatments. Cybin, a biopharma developing psychedelic-based treatment options for mental health issues.

In December 2021, worldwide clinical Trials and WCG partner to accelerate and streamline global safety event distribution. Worldwide offers a comprehensive suite of pharmacovigilance capabilities, including a regulatory intelligence database that is unique to the company and enhanced by WCG's proprietary Safety Vigilance portal.

Therapeutic Areas Covered:

Central Nervous System
Anti-Infective
Endocrine
Respiratory Diseases
Cardiovascular
Pain & Anaesthesia
Oncology
Dermatological Disorders
Haematological Disorders
Other Therapeutic Areas

Phases Covered:

Phase I
Phase II
Phase Ill
Phase IV

Age Groups Covered:

Child
Adult

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas

5.1 Introduction
5.2 Central Nervous System
5.3 Anti-Infective
5.4 Endocrine
5.5 Respiratory Diseases
5.6 Cardiovascular
5.7 Pain & Anesthesia
5.8 Oncology
5.9 Dermatological Disorders
5.10 Hematological Disorders
5.11 Other Therapeutic Areas

6 Global Clinical Trial Patient Recruitment Services Market, By Phase

6.1 Introduction
6.2 Phase I
6.3 Phase II
6.4 Phase Ill
6.5 Phase IV

7 Global Clinical Trial Patient Recruitment Services Market, By Age Group

7.1 Introduction
7.2 Child
7.3 Adult

8 Global Clinical Trial Patient Recruitment Services Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Clinical Site Services
10.2 Clara Health
10.3 Worldwide Clinical Trials
10.4 Clariness
10.5 Veristat
10.6 PPD Inc
10.7 BBK Worldwide
10.8 Elligo Health Research
10.9 Antidote Technologies, Inc.
10.10 IQVIA
10.11 Matthews Media Group Inc.
10.12 Conduent, Inc.
10.13 Biorasi, LLC
10.14 Trialfacts
10.15 Syneos Health